Trials / Completed
CompletedNCT01993290
USG Brachial Plexus Block for Upper Extremity Surgery
Ultrasound-guided Brachial Plexus Block With the Single-penetration Multiple-injection-technique for Upper Extremity Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Jens Borglum Neimann · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Ultrasound-guided (USG) brachial plexus (BP) block efficacy at the Supraclavicular (SCL), Lateral- Infraclavicular (LIC) and Axillary (AX) level: Randomized, observer-blinded study of the single-penetration multiple-injection-technique.
Detailed description
The investigators will compare the BP block efficacy (for surgical anaesthesia) with the USG single-penetration multiple-injection-technique at the SCL, LIC and AX level for upper-extremity surgery (elbow, forearm, wrist, hand). The investigators want to investigate whether the single-penetration multiple-injection-technique would provide for safe surgical anaesthesia with lower volumes of local anaesthetics than has previously been described in a comparative study at the three different levels. 120 patients will prospectively be randomized to an USG BP block administered as a single-penetration multiple-injection-technique at one of three different levels: (1) SCL (2) LIC (3) AX. Ropivacaine 0.75% (20 mL) will be used for all blocks prior to surgery.
Conditions
- Fracture at Wrist and/or Hand Level
- Rupture of Tendon of Wrist and Hand
- Injuries to the Wrist, Hand and Fingers (S60-S69)
- Ganglion Cysts
- Carpal Tunnel Syndrome
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | 20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-10-01
- Completion
- 2015-06-01
- First posted
- 2013-11-25
- Last updated
- 2015-07-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01993290. Inclusion in this directory is not an endorsement.